Obesity requires a spectrum of treatment options for effective results. Here, 3 key points to keep in mind when considering antiobesity medication for patients.
Jennifer Seger, MD
Advertisement
Articles by Jennifer Seger, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
Elinzanetant Improves Sleep Through VMS-Independent Mechanisms, According to New Pooled Analysis
2
Pooled Safety Analysis Supports Elinzanetant for Vasomotor Symptoms Through 52 Weeks
3
Four Studies Build Evidence for Elinzanetant as a Safe, Effective Nonhormonal Option for Menopausal Vasomotor Symptoms
4
Topline Real-World Data Show Fezolinetant Improves VMS, Sleep, and Work Productivity in Women With Confirmed Menopausal VMS
5
